DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI

Author(s) Chichareon P.; Modolo R.; Kawashima H.; Takahashi K.; Kogame N. et al.
Source JACC: Cardiovascular Interventions; Mar 2020; vol. 13 (no. 5); p. 634-646
Objectives: This study assessed the ability of the dual-antiplatelet therapy (DAPT) score in stratifying ischemic and bleeding risk in a contemporary percutaneous coronary intervention (PCI) population. Background(s): The DAPT score is recommended by guidelines as a tool to stratify ischemic and bleeding risk. Its utility in contemporary PCI is unknown.